Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in western Kenya

BACKGROUND: Anti-malarial drug resistance remains a major threat to global malaria control efforts. In Africa, Plasmodium falciparum remains susceptible to artemisinin-based combination therapy (ACT), but the emergence of resistant parasites in multiple countries in Southeast Asia and concerns over...

Descripción completa

Detalles Bibliográficos
Autores principales: Chebore, Winnie, Zhou, Zhiyong, Westercamp, Nelli, Otieno, Kephas, Shi, Ya Ping, Sergent, Sheila B., Rondini, Kelsey Anne, Svigel, Samaly Souza, Guyah, Benard, Udhayakumar, Venkatachalam, Halsey, Eric S., Samuels, Aaron M., Kariuki, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427724/
https://www.ncbi.nlm.nih.gov/pubmed/32795367
http://dx.doi.org/10.1186/s12936-020-03358-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427724/
https://www.ncbi.nlm.nih.gov/pubmed/32795367
http://dx.doi.org/10.1186/s12936-020-03358-7

Ejemplares similares